House dust mite sublingual allergen immunotherapy tablet is safe
and well-tolerated in Dutch clinical practice
SHORT Title: HDM SLIT-tablet safety in Dutch clinical practice
Žana Tempels-Pavlica1, Mark C.J.
Aarts2, Paco M.J. Welsing3,
Akke-Nynke van der Meer4, Leonard P. van der
Zwan5, Elena Uss5, André C.
Knulst6
1Department of Allergology, Diakonessenhuis, Utrecht,
The Netherlands
2Department of Otorhinolaryngology, Jeroen Bosch
Hospital, ‘s-Hertogenbosch, The Netherlands.
3Department of Rheumatology & Clinical Immunology,
University Medical Centre, Utrecht, The Netherlands.
4Department of Pulmonary Diseases, Medical Centre
Leeuwarden, Leeuwarden, The Netherlands
5Medical department, ALK-Abelló BV, Almere, The
Netherlands
6Department of Dermatology and Allergology, University
Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Corresponding author:
Žana Tempels-Pavlica, MD
Department of Allergology
Diakonessenhuis Utrecht
Bosboomstraat 1
3582 KE Utrecht
The Netherlands
Telephone: +31 (0)88 250 6604
E-mail:
ztempels@diakhuis.nl
Author ORCID
Žana Tempels-Pavlica
0009-0004-3315-0563
Mark C.J. Aarts 0009-0003-9120-3806
Paco M.J. Welsing 0000-0003-2361-2803
Akke-Nynke van der Meer 0009-0004-0563-4560
Leonard P. van der Zwan 0009-0001-2855-5900
Elena Uss 0009-0006-3901-8699
André C. Knulst 0000-0002-1056-3179